UNITED THERAPEUTICS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 233.8 USD | -0.89% |
|
-1.71% | +6.35% |
| 04-23 | United Therapeutics Insider Sold Shares Worth $1,704,174, According to a Recent SEC Filing | MT |
| 04-23 | United Therapeutics Q1 Results Could Fall Short of Market Expectations, Oppenheimer Says | MT |
Chart calendar United Therapeutics Corporation
8b46fb24caa8a7ed0ae1e4.dVrwVhlSJiJuf3O24umcqupvkjPkiBZlZ9DOyIGYeDs.DwvFI3MbakYfNAbVkrjGyIla_nysxiYXSpqekNb-IWNAFIRiXTR2fTQXBA~e7cc117540172da87e94e89f7008fcc3
Upcoming events on United Therapeutics Corporation
Past events on United Therapeutics Corporation
| 12/03/2024 17:40 | Leerink Partners Global Biopharma Conference |
| 05/03/2024 17:50 | TD Cowen Health Care Conference |
| 21/02/2024 14:00 | Q4 2023 Earnings Call |
| 21/02/2024 11:00 | Q4 2023 Earnings Release |
| 08/01/2024 19:15 | JPMorgan Healthcare Conference |
| 08/11/2023 15:00 | UBS BioPharma Conference - Fireside Chat |
| 01/11/2023 13:00 | Q3 2023 Earnings Call |
| 01/11/2023 10:00 | Q3 2023 Earnings Release |
| 11/09/2023 17:55 | Morgan Stanley Global Healthcare Conference |
| 02/08/2023 14:00 | Q2 2023 Earnings Call |
| 02/08/2023 11:00 | Q2 2023 Earnings Release |
| 26/06/2023 15:30 | Annual General Meeting |
| 25/06/2023 | Annual General Meeting |
| 24/05/2023 13:00 | American Thoracic Society International Conference - D28/501 |
| 24/05/2023 13:00 | American Thoracic Society International Conference - D28/505 |
| 23/05/2023 16:30 | American Thoracic Society International Conference - C36/P898 |
| 22/05/2023 16:30 | American Thoracic Society International Conference - B59/P209 |
| 22/05/2023 16:30 | American Thoracic Society International Conference - B59/P215 |
| 22/05/2023 16:30 | American Thoracic Society International Conference - B57/P168 |
| 22/05/2023 16:30 | American Thoracic Society International Conference - B57/P175 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 449 1 494 -3.01% | 1 483 1 460 1.57% | 1 686 1 702 -0.98% | 1 936 1 966 -1.51% | 2 328 2 292 1.57% | 2 699 |
|
EBITDA Million USD | Released Forecast Spread | -142 -48,8 -190.36% | 644 749 -14.08% | 606 665 -8.9% | 1 031 1 131 -8.82% | 1 238 1 221 1.38% | 1 398 |
|
EBIT Million USD | Released Forecast Spread | -188 -94,6 -98.31% | 594 702 -15.49% | 556 605 -8.18% | 980 1 086 -9.81% | 1 185 1 176 0.78% | 1 436 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -165 -88,9 -85.55% | 639 697 -8.34% | 594 665 -10.7% | 951 1 056 -9.99% | 1 274 1 243 2.5% | 1 490 |
|
Net income Million USD | Released Forecast Spread | -105 -49,6 -110.75% | 515 553 -6.83% | 476 533 -10.75% | 727 821 -11.38% | 985 978 0.69% | 1 195 |
|
EPS USD | Released Forecast Spread | -2,39 -1,13 -112.03% | 11,5 12,5 -7.9% | 10,1 11,4 -11.91% | 15,0 16,9 -11.4% | 19,8 19,7 0.68% | 24,0 |
| Announcement Date | 26/02/20 | 24/02/21 | 24/02/22 | 22/02/23 | 21/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 415 428 -2.9% | 462 420 9.97% | 467 461 1.27% | 516 493 4.57% | 492 519 -5.34% | 507 514 -1.45% | 597 524 13.8% | 609 586 4.03% | 615 576 6.74% | 623 | 688 | 713 | 719 |
|
EBITDA Million USD | Released Forecast Spread | 182 202 -9.83% | 301 214 40.18% | 215 233 -7.77% | 327 279 17.08% | 189 291 -35.17% | 298 261 14.06% | 326 | 340 301 13.06% | 274 209 31% | ||||
|
EBIT Million USD | Released Forecast Spread | 170 208 -18.19% | 288 194 48.11% | 202 235 -14.13% | 314 232 35.7% | 176 275 -36.04% | 284 277 2.5% | 313 280 12.03% | 327 309 5.69% | 260 252 3.22% | 335 | 371 | 383 | 377 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 141 215 -34.62% | 309 191 61.34% | 151 238 -36.79% | 313 225 38.94% | 179 276 -35.19% | 292 279 4.79% | 335 285 17.5% | 352 318 10.6% | 295 270 9.56% | 358 | 380 | 395 | 388 |
|
Net income Million USD | Released Forecast Spread | 112 174 -35.54% | 240 151 58.9% | 116 188 -38.2% | 239 183 30.87% | 132 221 -40.22% | 241 221 8.82% | 259 226 14.89% | 268 248 7.99% | 217 218 -0.48% | 281 | 308 | 320 | 306 |
|
EPS USD | Released Forecast Spread | 2,35 3,65 -35.69% | 5,03 3,07 63.77% | 2,41 3,96 -39.12% | 4,91 3,77 30.25% | 2,67 4,50 -40.72% | 4,86 4,50 7.89% | 5,24 4,49 16.79% | 5,38 5,04 6.68% | 4,36 4,19 4.15% | 5,64 | 6,08 | 6,31 | 5,99 |
| Announcement Date | 24/02/22 | 04/05/22 | 03/08/22 | 02/11/22 | 22/02/23 | 03/05/23 | 02/08/23 | 01/11/23 | 21/02/24 | - | - | - | - |
More events
Past sector events for United Therapeutics Corporation
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 06:00 | BB BIOTECH AG: Q1 2024 Earnings Release |
| 25/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 25/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 25/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 12:00 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 07:00 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- UTHR Stock
- Calendar United Therapeutics Corporation
